Cross Shawn 4
4 · Cyclo Therapeutics, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Cross Shawn
Director
Transactions
- Award
Common Stock
2024-11-15+17,228→ 107,749 total
Footnotes (1)
- [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $0.66 per share of common stock on November 14, 2024